[Dutch Medicines Act also applicable to repurposing].
In this issue of the Dutch Journal of Medicine (NTvG), Strous and Van den Brink argue that Article 68 of the Dutch Medicines Act should be applied to repurposed drugs in a more liberal manner. Medicines prescribed on-label have been authorised by the relevant regulatory authority and are therefore guaranteed to have been substantiated by the necessary evidence and assessed for a positive benefit-risk balance. Article 68 states that medicines may be prescribed off-label only if they are described in the relevant professional treatment standards or guidelines. The more liberal application of Article 68 would allow the prescription of drugs that have not been adequately assessed for evidence substantiating their efficacy and safety in the field for which they are being prescribed. This is unwarranted, for repurposed drugs and for any other drug.